Core Insights - DeepIntent has launched the HealthFirst™ Audio Package, aimed at providing healthcare advertisers with premium access to digital audio advertising [1][2] - The package includes curated supply from major audio platforms like iHeartMedia and SiriusXM, designed to enhance campaign performance by targeting patients and providers during high-attention moments [1][2] Group 1: Market Opportunity - Digital audio is becoming a significant component of omnichannel marketing strategies, with U.S. consumers expected to spend an average of 1 hour and 25 minutes per day on digital audio by 2025, nearly matching social media usage [2] - DeepIntent's analysis indicates that over 69% of healthcare providers can be reached through the HealthFirst™ Audio Package's premium inventory, highlighting a substantial market opportunity for healthcare advertisers [2] Group 2: Strategic Partnerships - iHeartMedia is a key partner in the HealthFirst™ Audio Package, emphasizing the growing demand for audio as a reliable medium in the pharmaceutical sector [3] - The partnership aims to provide healthcare brands with the necessary precision, quality, compliance, and scale to effectively reach their target audiences [3] Group 3: Product Features - The HealthFirst™ Audio Package is designed specifically for healthcare, offering optimized inventory from leading publishers, streamlined activation within the DeepIntent DSP, and a focus on transparency and trust in advertising [6][4] - The package allows for fast and easy setup for impactful campaign launches, ensuring that healthcare marketers can effectively engage with their audiences [6][4]

周一，Knorex(KNRX.US)登陆美股市场，截至发稿，该股跌超11%，报3.525美元。Knorex是一家B2B技 术公司，专注于为广告主和营销机构提供程序化广告解决方案和营销自动化服务。其核心产品是Knorex XPO平台，它结合AI/机器学习技术，支持跨渠道广告设置、预算优化、广告投放、自助管理、效果监 控等功能，覆盖社交媒体、搜索、视频、音频、流媒体电视、原生广告、数字户外等多个广告渠道。 来源：智通财经网 ...

周一，Knorex(KNRX.US)登陆美股市场，截至发稿，该股跌超11%，报3.525美元。Knorex是一家B2B技 术公司，专注于为广告主和营销机构提供程序化广告解决方案和营销自动化服务。其核心产品是Knorex XPO平台，它结合AI/机器学习技术，支持跨渠道广告设置、预算优化、广告投放、自助管理、效果监 控等功能，覆盖社交媒体、搜索、视频、音频、流媒体电视、原生广告、数字户外等多个广告渠道。 ...

Core Viewpoint - AppLovin's shares increased by up to 7.8% following a price target increase from Morgan Stanley and anticipation for the Axon Ads Manager launch for nongaming advertisers, which is seen as a key catalyst for expanding ad budgets beyond gaming [1][3]. Analyst Catalyst - Morgan Stanley raised its price target for AppLovin to $750 while maintaining an overweight rating, emphasizing the Axon Ads Manager rollout as crucial for scaling the company's nongaming business [3][7]. - Other analysts, including Piper Sandler and UBS, have also issued positive upgrades with targets of $740 and $810 respectively, reinforcing confidence in AppLovin's ability to diversify demand beyond gaming [3]. Valuation and Long-Term Outlook - AppLovin's shares are currently trading at high valuations, with a forward price-to-earnings ratio of approximately 50 and a price-to-sales ratio of around 42, reflecting expectations for rapid scaling of the Axon platform in the nongaming sector [4]. - The potential for sustained spending and acquiring recognizable nongaming clients could justify the current premium valuation [4]. Market Sentiment - There is significant enthusiasm for AppLovin's growth prospects, but the stock's recent rise may have already factored in much of the potential upside, making flawless execution critical for maintaining its valuation [5].

Accessibility StatementSkip Navigation LOS ANGELES, Sept. 26, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to PubMatic, Inc. ("PubMatic" or the "Company") (NASDAQ: PUBM) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PUBMATIC, INC. (PUBM), CLICK HERE BEFORE OCTOBER 20, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About? ...

Core Viewpoint - A class action securities lawsuit has been filed against PubMatic, Inc. for alleged securities fraud affecting investors between February 27, 2025, and August 11, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that defendants made false statements and concealed information regarding a significant shift of clients from a top demand side platform buyer to a new platform, which evaluated inventory differently [2]. - As a result of this shift, PubMatic experienced a reduction in ad spend and revenue from this top demand side platform buyer [2]. - The lawsuit claims that the defendants' positive statements about PubMatic's business, operations, and prospects were materially misleading and lacked a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses in PubMatic, Inc. during the specified time frame have until October 20, 2025, to request the Court to appoint them as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a 20-year track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - PubMatic, Inc. is facing a class action lawsuit due to alleged misleading statements regarding its business operations and financial outlook, particularly related to a significant reduction in ad spend from a top demand-side platform (DSP) partner [3][2]. Financial Performance - On August 11, 2025, PubMatic reported its second quarter 2025 financial results, revealing a decline in ad spend from a key DSP partner, which negatively impacted the company's revenue outlook [2]. - Following the announcement, PubMatic's share price dropped by $2.23, approximately 21.1%, from $10.57 to $8.34 per share [2]. Lawsuit Details - The class action lawsuit is on behalf of investors who purchased PubMatic securities between February 27, 2025, and August 11, 2025 [3]. - The lawsuit claims that the company failed to disclose critical information regarding the shift of clients to a new platform by a top DSP buyer, leading to reduced ad spend and revenue [3]. Legal Representation - Kirby McInerney LLP is the law firm representing the investors in this class action lawsuit, focusing on securities litigation and has a history of achieving significant recoveries for shareholders [4].

Core Insights - Deep-pocketed investors are adopting a bearish approach towards AppLovin, indicating potential significant market movements ahead [1] - The options activity for AppLovin shows a divided sentiment among investors, with 33% bullish and 44% bearish [2] Options Activity - A total of 154 extraordinary options activities were recorded for AppLovin, with 56 puts totaling $4,184,156 and 98 calls amounting to $9,204,161 [2] - Major market movers are focusing on a price band between $30.0 and $980.0 for AppLovin over the last three months [3] - The analysis of volume and open interest reveals liquidity and investor interest in AppLovin's options within the specified strike price range [4] Company Overview - AppLovin operates as a vertically integrated advertising technology company, generating approximately 80% of its revenue from its demand-side platform, AppDiscovery [11] - The company’s growth strategy is centered around AXON 2, an ad optimizer that helps advertisers place ads based on specified return thresholds [11] Market Standing - Recent analyst ratings for AppLovin show an average target price of $659.0, with various analysts maintaining their ratings and price targets ranging from $575 to $740 [13][14] - Current trading volume stands at 4,147,112, with the stock price at $634.03, reflecting a decrease of -1.23% [16]

Core Insights - Nexxen has launched a programmatic activation capability for native Smart TV advertising inventory, making it the first in the market to do so through its demand-side platform (DSP) [1][4][6] - Viewers spend an average of 10.5 minutes browsing content on Smart TV home screens, providing a significant opportunity for brands to engage with consumers during decision-making moments [2][5] - The new system streamlines the activation process for advertisers, allowing for real-time targeting and measurement of campaign outcomes [3][4] Company Overview - Nexxen is a global advertising technology platform that integrates data and advanced TV capabilities, offering a unified technology stack that includes both DSP and supply-side platform (SSP) [7] - The company aims to empower advertisers, agencies, publishers, and broadcasters by providing tools for discovery, planning, activation, monetization, measurement, and optimization [7] - Nexxen is headquartered in Israel and has a global presence with offices in the United States, Canada, Europe, and Asia-Pacific, and is publicly traded on NASDAQ under the ticker NEXN [8]

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, alleging that these companies made materially false and misleading statements regarding their business operations and prospects [1]. Group 1: PubMatic, Inc. (NASDAQ: PUBM) - The class period for PubMatic is from February 27, 2025, to August 11, 2025, with a lead plaintiff deadline of October 20, 2025 [2]. - Allegations include failure to disclose a significant shift of clients to a new platform by a top DSP buyer, resulting in reduced ad spend and revenue for PubMatic [2]. - Defendants' positive statements about the company's business were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Snap Inc. (NYSE: SNAP) - The class period for Snap is from April 29, 2025, to August 5, 2025, with a lead plaintiff deadline of October 20, 2025 [3]. - The complaint alleges that Snap's optimistic reports on advertising growth were misleading, as they relied too heavily on the company's execution capabilities [3]. - Defendants failed to disclose significant execution errors and macroeconomic challenges, leading to materially misleading statements about the company's prospects [3]. Group 3: Nutex Health Inc. (NASDAQ: NUTX) - The class period for Nutex is from August 8, 2024, to August 14, 2025, with a lead plaintiff deadline of October 21, 2025 [4]. - Allegations include engaging in a scheme to defraud insurance companies, leading to unsustainable revenue claims [4]. - The company overstated its ability to remediate internal control weaknesses, resulting in improper accounting of stock-based compensation obligations [4]. Group 4: C3.ai, Inc. (NYSE: AI) - The class period for C3.ai is from February 26, 2025, to August 8, 2025, with a lead plaintiff deadline of October 21, 2025 [6]. - The complaint alleges that the company's optimistic growth reports were misleading, relying heavily on the CEO's health and effectiveness [6]. - Defendants failed to disclose that the CEO had not sufficiently recovered to fulfill his role, leading to materially misleading statements about the company's prospects [6].